Unlock Health, Inc. – Trademark Portfolio
Entity Type: 03
Unlock Health, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ERUPTR and UNLOCK HEALTH. The owner is based in Nashville, TN.
209 10th Avenue South, Suite 530
Nashville, TN 37203
Showing of trademarks Trademarks
Trademark Classifications
Unlock Health, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Unlock Health, Inc. have?
Unlock Health, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 abandoned.
What trademark classes does Unlock Health, Inc. file in?
Unlock Health, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are Unlock Health, Inc.'s most well-known trademarks?
Unlock Health, Inc.'s registered trademark portfolio includes well-known marks such as ERUPTR and UNLOCK HEALTH. These are among 2 currently registered trademarks in the portfolio.
What is Unlock Health, Inc.'s trademark registration success rate?
Unlock Health, Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.